Macular edema (ME) represents the most common cause for visual loss among uveitis
patients. The management of uveitic macular edema (UME) may be challenging, due to its …

Background: Based on experimental studies and clinical observations by Robert Machemer,
Gholam Peyman and others, the vitreous cavity has increasingly been used as a reservoir of …

Objectives: To evaluate the safety and efficacy of 0.59-mg and 2.1-mg fluocinolone
acetonide (FA) intravitreous implants in noninfectious posterior uveitis. Design: A 3-year …

Optical coherence tomography (OCT) is a non-contact noninvasive technique that allows in
vivo imaging of the retina, choroid, optic nerve head, retinal nerve fiber layer, and the …

Background Uveitic macular edema is the major cause of reduced vision in eyes with uveitis.
Objectives To assess the effectiveness of interventions in the treatment of uveitic macular …

Background: To provide an update on the intravitreal use of triamcinolone acetonide.
Methods: Review of literature regarding triamcinolone-related research. Results: After the …

Macular edema (ME) is the leading cause of visual loss in uveitis and may persist long after
ocular inflammation has been resolved. Local steroids are the first line treatment for uveitis …

PURPOSE: To compare the management and outcome of raised intraocular pressure (IOP)
in uveitis patients with a corticosteroid hypertensive response and those who are …

Triamcinolone acetonide (TA) is a corticosteroid that has many uses in the treatment of
ocular diseases because of its potent anti-inflammatory and anti-permeability actions …

Purpose Clinical data suggest a role for VEGF in uveitic cystoid macular oedema (CME),
even though the data on intravitreal VEGF levels in these eyes is still inconclusive. We …